Searched for
FULFORD INDIA LTD.
Merck arm Fulford faces delisting setback after promoter Dashtag failed to comply with clause; stock plunges 5% intradayDashtag, the holding company of Fulford, did not submit the acknowledgement for the delivery of the open offer letters to a few shareholder...- Sensex rangebound ahead of F&O expiry; top ten stocks in focusAt 10:00 a.m.; Sensex was at 8,265.65, down 1.1 points or 0.01 per cent. It touched a high of 8,286.40 and a low of 8,255.35 in trade today.
- Ten stocks in focus in Wednesday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Fulford India divests consumer care biz to Bayer Pharmaceuticals Private LtdBayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.
- BSE tweaks circuit limit for shares of Jet Airways, 19 othersBSE today revised the permissible daily trading limit for shares of Jet Airways and 19 other companies, as part of a surveillance action.
- MSD launches medical, healthcare website called 'Univadis'Univadis is an online resource for healthcare professionals launched in 40 countries, available in 17 languages, with 20 mn registered user...
- Cipla to market MSD's HIV drug 'raltegravir' in IndiaMSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...
- Open offers pour in as promoters take advantage of lower valuationsNearly 10 proposals are expected in the weeks ahead; open offers seen mostly for small-cap companies.
- MSD India eyes more partnerships to widen product presenceDrug firm MSD India today said it is looking for commercial partnerships, such as the one that it has with Sun Pharma.
- Merck scouts for marketing, licensing pacts with Indian cosMerck & Co, is looking at in-licensing and co-marketing arrangements with Indian pharma cos as it wants to realise its ambitions to become ...
- Merck scouting for Indian partnersMerck is looking at partnerships with Indian firms that have their own R&D and manufacturing capability, says chief executive designate Ken...
- Relocation triggers exits at Merck armAround 50 executives quit MSD, the Indian arm of Merck & Co, in the past few months — most opted out due to the company’s decision to reloc...
- HC rejects Fulford plea against United Biotech, Oscar RemediesWhen a trademark is derived from the common generic name, no single proprietor can claim absolute monopoly in such name or trade mark, rule...
- Merck buys Schering-Plough in $41.1b cash-&-stock dealUS-based Merck & Co is acquiring Schering-Plough for $41.1 billion in a cash-and-stock deal, to create a $47 billion drug major.
- Merck buys Schering-Plough for $41 bn to access new drugsUS-based Merck & Co on Monday said it is acquiring Schering Plough for $41.1 bn in a cash-and-stock deal to create a $42-bn drug major.
- Earnings on Wednesday: BASF, FulfordCompanies scheduled to announce their earnings for the quarter / year ended March 31, 2008, today are:
- Dashtag makes open offer for additional 20 pcIn order to further consolidate its stake in Fulford India, UK-based Dashtag has made an open offer to the shareholders for acquiring 20 pe...
- Goldman buys 7% in Fulford India for Rs 13 crGoldman Sachs’ private equity fund has bought 7% in Fulford India, an affiliate of the US-based pharma firm, Schering-Plough, for Rs 13 cro...
- UTI to cut exposure in some, pump more funds in othersNEW DELHI: The Unit Trust of India is reviewing its investment decisions in various companies. In a presentation to JPC, UTI has stated tha...
Load More
